T Brzostek
Overview
Explore the profile of T Brzostek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Metz D, Urban P, Meier B, Hoang V, Camenzind E, Brzostek T, et al.
Arch Mal Coeur Vaiss
. 1994 Sep;
87(9):1153-9.
PMID: 7646228
Between April 1988 and September 1993, 123 patients (average age 60.4 +/- 8.9 years) underwent coronary stenting for threatening or occlusive dissection complicating angioplasty. The anterograde coronary flow was disturbed...
12.
Brzostek T, Van de Werf F, Mortelmans L, Scheys I, Lesaffre E, Dubiel J, et al.
Eur Heart J
. 1994 May;
15(5):641-7.
PMID: 8056004
Thrombolytic therapy salvages jeopardized myocardium and preserves left ventricular function. Therefore, a beneficial effect on exercise tolerance and haemodynamic adaptation to exercise can be anticipated. In the present study the...
13.
Brzostek T, Van de Werf F, Scheys I, Lesaffre E, Dubiel J, De Geest H
Acta Cardiol
. 1994 Jan;
49(1):9-24.
PMID: 8184642
The incidence of recurrent ischemia, congestive heart failure and death during the first year after discharge were analysed prospectively in a group of 312 patients randomized double blindly to rt-PA...
14.
Mortelmans L, Nuyts J, Scheys I, Wackers F, Lesaffre E, Brzostek T, et al.
Eur J Nucl Med
. 1993 Dec;
20(12):1193-200.
PMID: 8299655
In this study a new method for assessment of perfusion defects (PDs) derived from myocardial perfusion tomograms was evaluated in patients treated with thrombolytic therapy. Using global constraints and dynamic...
15.
Van de Werf F, Janssens L, Brzostek T, Mortelmans L, Wackers F, Willems G, et al.
J Am Coll Cardiol
. 1993 Aug;
22(2):407-16.
PMID: 8335810
Objectives: This study was conducted to explore mechanisms that could explain the possible clinical benefit of early administration of a beta 1-selective adrenoreceptor blocking agent or a bradycardiac drug as...
16.
Mortelmans L, Scheys I, Brzostek T, Lesaffre E, De Roo M, Verstraete M, et al.
Nuklearmedizin
. 1993 Jun;
32(3):120-7.
PMID: 8327330
The aim of the study was the functional re-evaluation of 296 patients 12 to 18 months after a double-blind trial evaluating the effect of tissue plasminogen activator (rt-PA) versus placebo...
17.
Dubiel J, Jaskiewicz J, Zmudka K, Brzostek T, Surdacki A
Eur J Clin Pharmacol
. 1992 Jan;
42(2):217-8.
PMID: 1618255
The percentage composition of free fatty acids in the coronary circulation has been studied during the passage of blood through the heart in patients with hypertrophic cardiomyopathy. Under basal conditions...
18.
Dubiel J, Zmudka K, Surdacki A, Brzostek T, Jaskiewicz J, Dimitrow P, et al.
Cor Vasa
. 1992 Jan;
34(5-6):373-81.
PMID: 1339710
Unlabelled: A decrease in the myocardial extraction or excretion of lactates indicates its hypoxia. The authors analyzed changes in the extraction of lactates, non-esterified fatty acids (NEFA) and their fractions:...
19.
Dubiel J, Zmudka K, Brzostek T
Pol Tyg Lek
. 1991 May;
46(22-23):409-11.
PMID: 1669076
The aim of the study was to investigate whether oxygen causes a further decrease in pulmonary artery pressure after administration of calcium channel blocker-verapamil-or angiotensin converting enzyme inhibitor-captopril-in the secondary...
20.
Dubiel J, Bacior B, Brzostek T
Pol Tyg Lek
. 1991 Jan;
46(1-3):22-4.
PMID: 1845661
Selected parameters of the pulmonary circulation and right ventricular performance were studied in 30 patients with primary arterial hypertension. Four patients belonged to the WHO class I, four to class...